Compugen Company Leadership
| CGEN Stock | USD 1.76 0.05 2.92% |
Compugen employs about 74 people. The company is managed by 15 executives with a total tenure of roughly 27 years, averaging almost 1.0 years of service per executive, having 4.93 employees per reported executive. Analysis of Compugen's management performance can provide insight into the firm performance.
| Anat CohenDayag CEO President CEO, Director |
Compugen Management Team Effectiveness
The company has return on total asset (ROA) of (0.1818) % which means that it has lost $0.1818 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5295) %, meaning that it created substantial loss on money invested by shareholders. Compugen's management efficiency ratios could be used to measure how well Compugen manages its routine affairs as well as how well it operates its assets and liabilities. As of the 11th of February 2026, Return On Tangible Assets is likely to drop to -0.15. In addition to that, Return On Capital Employed is likely to drop to -0.15. At this time, Compugen's Asset Turnover is very stable compared to the past year.As of the 11th of February 2026, Common Stock Shares Outstanding is likely to grow to about 108.1 M, while Net Loss is likely to drop (31.8 M). Compugen holds a total of 93.54 Million outstanding shares. Almost 84.46 percent of Compugen outstanding shares are held by general public with 2.02 (percent) owned by insiders and only 13.52 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Shares in Circulation | First Issued 2000-03-31 | Previous Quarter 93.5 M | Current Value 93.5 M | Avarage Shares Outstanding 47.5 M | Quarterly Volatility 23.8 M |
Compugen Workforce Comparison
Compugen is rated fourth in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 697. Compugen retains roughly 74.0 in number of employees claiming about 11% of equities under Health Care industry.
Compugen Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Compugen Price Series Summation is a cross summation of Compugen price series and its benchmark/peer.
Compugen Notable Stakeholders
A Compugen stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Compugen often face trade-offs trying to please all of them. Compugen's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Compugen's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Anat CohenDayag | President CEO, Director | Profile | |
| Zurit Levine | VP of Research and Discovery | Profile | |
| Alberto Sessa | Chief Officer | Profile | |
| Rivka Schwartz | Vice Discovery | Profile | |
| Henry MD | Senior Officer | Profile | |
| Eran Ophir | Chief Officer | Profile | |
| Michelle MD | Chief Officer | Profile | |
| Yvonne Naughton | Head Communications | Profile | |
| David CPA | Chief Officer | Profile | |
| Dorit Amitay | Vice Resources | Profile | |
| Eran Dor | General Secretary | Profile | |
| Oliver Froescheis | Sr Devel | Profile | |
| Pierre Ferre | Senior Operations | Profile | |
| Yaron MBA | Senior Solutions | Profile |
About Compugen Management Performance
The success or failure of an entity such as Compugen often depends on how effective the management is. Compugen management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Compugen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Compugen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.14) | (0.15) | |
| Return On Capital Employed | (0.14) | (0.15) | |
| Return On Assets | (0.14) | (0.15) | |
| Return On Equity | (0.30) | (0.31) |
Compugen Workforce Analysis
Traditionally, organizations such as Compugen use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Compugen within its industry.Compugen Manpower Efficiency
Return on Compugen Manpower
| Revenue Per Employee | 376.5K | |
| Revenue Per Executive | 1.9M | |
| Net Loss Per Employee | 192.3K | |
| Net Loss Per Executive | 948.7K | |
| Working Capital Per Employee | 1.2M | |
| Working Capital Per Executive | 5.7M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compugen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in discontinued. To learn how to invest in Compugen Stock, please use our How to Invest in Compugen guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Will Life Sciences Tools & Services sector continue expanding? Could Compugen diversify its offerings? Factors like these will boost the valuation of Compugen. Projected growth potential of Compugen fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Compugen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.30) | Revenue Per Share | Quarterly Revenue Growth (0.89) | Return On Assets | Return On Equity |
Investors evaluate Compugen using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Compugen's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Compugen's market price to deviate significantly from intrinsic value.
It's important to distinguish between Compugen's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Compugen should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Compugen's market price signifies the transaction level at which participants voluntarily complete trades.